PMDA drug package insert
アイモビーグ皮下注70mgペン
PMDA Prescription drug · アムジェン株式会社 · package insert Feb 28, 2023
Key facts
| Brand names | アイモビーグ皮下注70mgペン |
|---|---|
| Nonproprietary names | エレヌマブ（遺伝子組換え） |
| Companies | 製造販売／アムジェン株式会社 |
| Product type | Prescription drug |
| Therapeutic category | ヒト抗CGRP受容体モノクローナル抗体製剤 |
| Therapeutic category codes | 871190 |
| YJ codes | 1190406G1029 |
| Approval numbers | 30300AMX00290000 |
| Package insert edition | 第4版 |
| Package insert date | Feb 28, 2023 |
| PMDA document key | 112292_1190406G1029_2 |
| PMDA company code | 112292 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: